OCTREOTIDE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 124 adverse event reports in the FDA FAERS database where OCTREOTIDE was used for Off label use.
Most Reported Side Effects for OCTREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,801 | 16.0% | 3,790 | 994 |
| Diarrhoea | 3,621 | 15.3% | 551 | 1,907 |
| Fatigue | 2,933 | 12.4% | 512 | 1,681 |
| Blood pressure increased | 2,799 | 11.8% | 478 | 1,641 |
| Needle issue | 2,740 | 11.6% | 217 | 864 |
| Malaise | 2,737 | 11.5% | 520 | 1,680 |
| Pain | 2,366 | 10.0% | 427 | 1,469 |
| Blood pressure systolic increased | 2,340 | 9.9% | 519 | 1,438 |
| Malignant neoplasm progression | 2,306 | 9.7% | 610 | 1,109 |
| Nausea | 2,294 | 9.7% | 377 | 1,306 |
| Injection site pain | 2,123 | 9.0% | 315 | 1,164 |
| Abdominal pain | 2,033 | 8.6% | 380 | 1,310 |
| Asthenia | 1,975 | 8.3% | 543 | 1,330 |
| Weight decreased | 1,950 | 8.2% | 440 | 1,236 |
| Inappropriate schedule of product administration | 1,921 | 8.1% | 334 | 989 |
Other Indications for OCTREOTIDE
Product used for unknown indication (6,866)
Neuroendocrine tumour (4,587)
Acromegaly (3,068)
Carcinoid tumour (2,148)
Carcinoid syndrome (1,367)
Pancreatic neuroendocrine tumour (647)
Gastroenteropancreatic neuroendocrine tumour disease (387)
Diarrhoea (338)
Neuroendocrine carcinoma (251)
Metastatic carcinoid tumour (192)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)